Nucleic Acid Therapeutics Congress: Asia

Nucleic Acid Therapeutics Congress: Asia is organized by Global Engage Ltd and will be held from Sep 09 - 10, 2025 at Singapore, Singapore, Singapore.

Description:
The 2-day conference, run on single-track highlight these emerging trends and offer a platform for academic researchers, biotechnology and pharmaceutical industry professionals, healthcare providers, and regulatory experts to share latest insights on the development of these transformative therapies, including:

• DNA and RNA processing & mechanism and editing
• Oligonucleotide design and chemistry
• Gene editing and CRISPR technology
• AI-assisted nucleic acid research
• Concept to clinic: research to clinical translation and commercialization
• Emerging trends – Challenges and future of vaccine

Why Attend:

• Cutting-Edge Research: Access the latest developments in nucleic acid therapeutics, including RNA-based therapies, gene editing technologies, and emerging applications in personalized medicine
• Expert Insights: Learn from leading researchers and industry experts through keynote presentations, panel discussions, and workshops that delve into current challenges and future directions in the field
• Networking Opportunities: Connect with fellow scientists, researchers, and industry professionals, fostering collaborations that can enhance research initiatives and advance therapeutic developments
• Collaborative Environment: Engage in discussions with peers from diverse backgrounds, facilitating the exchange of ideas and best practices in nucleic acid research
• Regulatory Insights: Gain valuable insights into the regulatory landscape affecting nucleic acid therapies, helping you navigate compliance and market approval processes
• Impact on Healthcare: Be part of the conversation on how nucleic acid therapeutics are transforming approaches to treating diseases, allowing you to contribute to impactful research that can benefit patients worldwide.